InVivo Therapeutics Holdings Corp (NASDAQ:NVIV)

5.80
Delayed Data
As of Jun 15
 -0.88 / -13.17%
Today’s Change
5.80
Today|||52-Week Range
96.25
-69.87%
Year-to-Date

Five Year Financial Summary

Total Revenue

Cash & Short Term Investments

Cash From Operations

All Currency in US Dollars4 Year
Trend

2014

2015

2016

2017
Revenue and IncomeNet Revenues0.000.000.000.00--
Depreciation And Amortization752.0K689.0K553.0K395.0K
 
 
 
 
 
 
Operating ExpensesGross Income-752.0K-689.0K-553.0K-395.0K
 
 
 
 
 
General Expenses17.1M21.7M23.5M23.3M
 
 
 
 
 
Research And Development10.3M10.1M12.6M10.4M
 
 
 
 
 
Total Operating Expenses17.8M22.4M24.1M23.7M
 
 
 
 
 
 
Non-Operating ExpensesOperating Income-17.8M-22.4M-24.1M-23.7M
 
 
 
 
 
Extraordinary Credit--0.00593.0K0.00
 
 
Extraordinary Charge-376.0K-10.8M0.00-3.2M
 
 
 
 
Interest Expense On Debt136.0K172.0K155.0K74.0K
 
 
 
 
 
 
Income Taxes, Minority Interest and Extra ItemsPre-Tax Income-18.3M-33.3M-23.4M-26.7M
 
 
 
 
 
Net Income-18.3M-33.3M-23.4M-26.7M
 
 
 
 
 
 
Shares To Calculate EPSShares To Calculate EPS883.2K1.1M1.2M1.3M
 
 
 
 
 
Shares To Calculate EPS Diluted883.2K1.1M1.2M1.3M
 
 
 
 
 
 
Earnings Per ShareEPS-$21.00-$31.50-$19.00-$20.25
 
 
 
 
 
EPS Diluted-$21.00-$31.50-$19.00-$20.25